Two-year data from Eli Lilly’s SURPASS-EARLY trial show reduced A1c, body weight, and cardiovascular risk factors. Medscape Medical News Source link : https://www.medscape.com/viewarticle/early-introduction-tirzepatide-yields-t2d-benefits-2026a10007pu?src=rss Author : Publish date : 2026-03-12 18:19:00...
Read more


















